STYLAGE® S BI-SOFT®

Description

Name: Stylage® S BI-SOFT®
Manufacturer: Vivacy
Active Substance(s): CROSS LINKED HYALURONIC ACID, MANNITOL, PHOSPHATE BUFFER PH 7.2
Strength: 16mg/g HA, 9mg/ml Mannitol
Pack Size: 2-0.8ml prefilled syringes
Accessories: 2 x 0.8ml Pre-Filled Syringes, 4 x 30 G ½ Needles

STYLAGE® S BI-SOFT® is a monophasic injectable dermal filler formulated to correct fine lines and superficial wrinkles, such as crow’s feet and perioral lines. Developed by Laboratoires VIVACY, it combines cross-linked hyaluronic acid with Mannitol, a powerful antioxidant that enhances the stability and comfort of the product. Engineered using IPN-Like Technology, the gel offers optimized elasticity and spreadability, providing a smooth, natural appearance. With the ergonomic Bi-SOFT® Injection Technology, practitioners gain greater control and precision during treatment.

• Concentration: 16 mg/g of cross-linked hyaluronic acid
• Indicated for: Superficial to mid-dermis injections targeting fine to medium wrinkles
• Duration: Visible effects last between 6 to 12 months

STYLAGE® S BI-SOFT® is packaged in a sterile format with 2 x 0.8 ml prefilled syringes per box. Each syringe features the patented Bi-SOFT® delivery system, enhancing grip, control, and comfort for the injector. It comes with 30G½’’ needles and uses color-coded caps for quick product identification. Each unit also integrates an RFID chip to authenticate product origin and prevent counterfeiting.

The product formulation is a unique combination of bio-compatible, high-performance ingredients:

• Cross-linked hyaluronic acid (16 mg/g) using IPN-Like Technology
• Mannitol, an antioxidant that protects against oxidative stress and hyaluronic acid degradation
• Phosphate buffer ensuring iso-osmolarity and patient comfort
• Optionally available with 0.3% Lidocaine for pain relief during injection
  

STYLAGE® S BI-SOFT® is designed for the correction of fine lines and superficial wrinkles, such as glabella lines, crow’s feet, and perioral wrinkles. Its smooth texture and elasticity allow for a natural integration into superficial dermal layers. It is especially suitable for patients seeking a refined, non-bulky correction of early aging signs.

Indications:

• Fine wrinkles (e.g., crow’s feet, glabella lines)
• Perioral lines and superficial creases
• Injection depth: Superficial to mid-dermis
  

Contraindications:

• Known allergy to hyaluronic acid, Mannitol, or Lidocaine
• Pregnant or breastfeeding women
• Active infections, inflammation, or autoimmune disorders at or near the treatment site
  

Side Effects:

• Temporary redness, swelling, pain, or bruising
• Induration and sensitivity may occur
• Most side effects resolve within 7 days on average
  

STYLAGE® S BI-SOFT® is administered via intradermal injection using a 30G½’’ needle into the superficial to mid-dermis. The practitioner may employ common techniques such as retrograde linear threading, micro-bolus, or multi-point injection based on the wrinkle location and desired result. The Bi-SOFT® syringe system allows for improved ergonomics, enhanced visibility, and smoother pressure application during use.

Injection Techniques:

• Retrograde linear threading
• Micro-bolus injection
• Serial puncture or multi-point injection
  

Storage Conditions:

• Store between 2°C and 25°C
• Protect from light, moisture, and freezing
• Do not use past the expiry date on packaging

Adhering to recommended storage and injection protocols helps preserve the viscoelastic properties and sterility of the product, ensuring both safety and performance throughout its use.

Warning! The product is intended solely for professional use in a medical environment and under professional supervision. The product is supplied to medical professionals who specialize in aesthetic medicine (plastic surgery, facial treatments) and work under individual medical licenses as aestheticians or in dedicated clinics. Unprofessional use by individuals without a medical background may lead to severe adverse effects and health harm.